- Home
- ELVN vs SKT Comparison
ELVN vs SKT Comparison
Compare ELVN & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | SKT |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | United States |
| Employees | N/A | 477 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.3B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ELVN | SKT |
|---|---|---|
| Price | $57.95 | $37.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | ★ $43.40 | $37.17 |
| AVG Volume (30 Days) | ★ 1.0M | 722.2K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.37 |
| Revenue Next Year | N/A | $3.90 |
| P/E Ratio | ★ N/A | $71.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $31.13 |
| 52 Week High | $62.32 | $42.53 |
Technical Indicators
Market Signals| Indicator | ELVN | SKT |
|---|---|---|
| Relative Strength Index (RSI) | 58.95 | 34.53 |
| Support Level | $56.69 | $34.97 |
| Resistance Level | $62.32 | $37.95 |
| Average True Range (ATR) | 1.92 | 0.54 |
| MACD | -0.28 | -0.09 |
| Stochastic Oscillator | 57.25 | 11.04 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About SKT Tanger Inc.
Tanger Inc is an owner and operator of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers.